Nutcracker Therapeutics Named Industry Veteran Samuel Deutsch as Chief Scientific Officer
EMERYVILLE, Calif.--(BUSINESS WIRE)--Jan 8, 2024--
Source: eagletribune.com
Nutcracker Therapeutics News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Nutcracker Therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Nutcracker Therapeutics Today - Breaking & Trending Today
Biochips Market size is set to grow by USD 43,273.01 million from 2022 to 2027, North America to account for 41% of the global market growth
/PRNewswire/ -- The global biochips market size is estimated to grow by USD 43,273.01 million from 2022 to 2027, according to Technavio. The market is...
Source: prnewswire.com
Biochips Market size is set to grow by USD 43,273.01 million from 2022 to 2027; The growing use of personalized medicines to boost the market
/PRNewswire/ -- The global biochips market size is estimated to grow by USD 43,273.01 million from 2022 to 2027, according to Technavio. The market is...
Source: prnewswire.com
Nutcracker Therapeutics Adds Dr. Thomas J. Dietz to Board of Directors
EMERYVILLE, Calif.--(BUSINESS WIRE)--Nutcracker Therapeutics, Inc., a biotechnology company dedicated to developing transformative RNA therapies through its proprietary technology platform, today announced the appointment of Thomas J. Dietz, Ph.D., to the company’s board of directors.Dr. Dietz brings to Nutcracker T...
Source: pharmiweb.com
Nutcracker Therapeutics to Present Data for Lead Candidate at 2022 SITC Annual Meeting
EMERYVILLE, Calif.--(BUSINESS WIRE)--Nutcracker Therapeutics, Inc., a biotechnology company dedicated to developing transformative RNA therapies through its proprietary technology platform, today announced the upcoming poster presentation of new preclinical data for its lead therapeutic candidate, NTX-0250, which ta...
Source: pharmiweb.com